Literature DB >> 28199701

Hepatitis E Virus Infects Neurons and Brains.

Xinying Zhou1, Fen Huang2, Lei Xu1, Zhanmin Lin3, Femke M S de Vrij4, Ane C Ayo-Martin4, Mark van der Kroeg4, Manzhi Zhao1, Yuebang Yin1, Wenshi Wang1, Wanlu Cao1, Yijin Wang1, Steven A Kushner4, Jean Marie Peron5,6, Laurent Alric6,7, Robert A de Man1, Bart C Jacobs8,9, Jeroen J van Eijk10, Eleonora M A Aronica11, Dave Sprengers1, Herold J Metselaar1, Chris I de Zeeuw3,12, Harry R Dalton13,14, Nassim Kamar7,15,16, Maikel P Peppelenbosch1, Qiuwei Pan1.   

Abstract

Hepatitis E virus (HEV), as a hepatotropic virus, is supposed to exclusively infect the liver and only cause hepatitis. However, a broad range of extrahepatic manifestations (in particular, idiopathic neurological disorders) have been recently reported in association with its infection. In this study, we have demonstrated that various human neural cell lines (embryonic stem cell-derived neural lineage cells) induced pluripotent stem cell-derived human neurons and primary mouse neurons are highly susceptible to HEV infection. Treatment with interferon-α or ribavirin, the off-label antiviral drugs for chronic hepatitis E, exerted potent antiviral activities against HEV infection in neural cells. More importantly, in mice and monkey peripherally inoculated with HEV particles, viral RNA and protein were detected in brain tissues. Finally, patients with HEV-associated neurological disorders shed the virus into cerebrospinal fluid, indicating a direct infection of their nervous system. Thus, HEV is neurotropic in vitro, and in mice, monkeys, and possibly humans. These results challenge the dogma of HEV as a pure hepatotropic virus and suggest that HEV infection should be considered in the differential diagnosis of idiopathic neurological disorders.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  central nervous system; cerebrospinal fluid; hepatitis E virus; peripheral nervous system.

Mesh:

Substances:

Year:  2017        PMID: 28199701     DOI: 10.1093/infdis/jix079

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

Review 1.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 2.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

3.  Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system.

Authors:  Debin Tian; Wen Li; C Lynn Heffron; Bo Wang; Hassan M Mahsoub; Harini Sooryanarain; Anna M Hassebroek; Sherrie Clark-Deener; Tanya LeRoith; Xiang-Jin Meng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-07       Impact factor: 12.779

4.  Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.

Authors:  Changbo Qu; Shaoshi Zhang; Wenshi Wang; Meng Li; Yijin Wang; Marieke van der Heijde-Mulder; Ehsan Shokrollahi; Mohamad S Hakim; Nicolaas J H Raat; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  FASEB J       Date:  2018-08-02       Impact factor: 5.191

Review 5.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

6.  Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1.

Authors:  Yunlong Li; Zhijiang Miao; Pengfei Li; Ruyi Zhang; Denis E Kainov; Zhongren Ma; Robert A de Man; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Arch Virol       Date:  2021-05-14       Impact factor: 2.574

7.  Novel orthohepeviruses in wild rodents from São Paulo State, Brazil.

Authors:  William Marciel de Souza; Marilia Farignoli Romeiro; Gilberto Sabino-Santos; Felipe Gonçalves Motta Maia; Marcilio Jorge Fumagalli; Sejal Modha; Marcio Roberto Teixeira Nunes; Pablo Ramiro Murcia; Luiz Tadeu Moraes Figueiredo
Journal:  Virology       Date:  2018-04-05       Impact factor: 3.616

8.  High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.

Authors:  Yue Feng; Yue-Mei Feng; Songmei Wang; Fang Xu; Xuehui Zhang; Chunyue Zhang; Yuanyuan Jia; Wanru Yang; Xueshan Xia; Jianzhong Yin
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

9.  Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.

Authors:  Changbo Qu; Lei Xu; Yuebang Yin; Maikel P Peppelenbosch; Qiuwei Pan; Wenshi Wang
Journal:  Arch Virol       Date:  2017-06-16       Impact factor: 2.574

10.  Experimental infection of hepatitis E virus induces pancreatic necroptosis in miniature pigs.

Authors:  Soontag Jung; Dong Joo Seo; Daseul Yeo; Zhaoqi Wang; Ae Min; Ziwei Zhao; Mengxiao Song; In-Soo Choi; Jinjong Myoung; Changsun Choi
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.